شرکت‌سرم‌سازی‌شهیدقاضی‌تبریز

دقاضی | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 24,040 1.78
Close Price: 23,520

Cash Flow

2026/05/12
Fiscal Year 2026/03/2012 Month
2026/04/28
Fiscal Year 2026/03/2012 Month / Audited

Cash Generated from Operations

3.535 Trillion3.535 Trillion

Income Taxes Paid

-394.284 Billion-394.284 Billion

Net Cash Flow from Operating Activities

3.141 Trillion3.141 Trillion

Purchases of Property, Plant and Equipment

-788.859 Billion-788.859 Billion

Purchases of Intangible Assets

-3.85 Billion-3.85 Billion

Proceeds from Sale of Short-Term Investments

40 Million40 Million

Dividends Received

9.169 Billion9.169 Billion

Cash Received from Income on Other Investments

555 Million555 Million

Net Cash Flow from Investing Activities

-782.945 Billion-782.945 Billion

Net Cash Flow before Financing Activities

2.358 Trillion2.358 Trillion

دریافت های نقدی حاصل از افزايش سرمایه

27.591 Billion27.591 Billion

Proceeds from Sale of Treasury Shares

25.926 Billion25.926 Billion

Purchases of Treasury Shares

-29.473 Billion-29.473 Billion

Cash Received from Borrowings

11.775 Trillion11.775 Trillion

Repayments of Borrowings (Principal)

-7.63 Trillion-7.63 Trillion

Interest Paid on Borrowings

-701.276 Billion-701.276 Billion

Interest Paid on Participation Bonds

-1.454 Trillion-1.454 Trillion

Dividends Paid

-4.801 Trillion-4.801 Trillion

Net Cash Flow from Financing Activities

-2.788 Trillion-2.788 Trillion

Net Increase (Decrease) in Cash

-430.337 Billion-430.337 Billion

Cash at Beginning of Period

1.064 Trillion1.064 Trillion

Effect of Exchange Rate Changes

267.899 Billion267.899 Billion

Cash at End of Period

1.332 Trillion1.332 Trillion

Non-Cash Transactions

-468.255 Billion